December 8, 2025 (U.S.) – Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference – Global healthcare giant Johnson & Johnson (NYSE: JNJ) has announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference, one of the world’s premier investor and industry events focused on innovation and trends in the life sciences and healthcare sectors. The conference will take place in San Francisco, California from January 12–15, 2026, with Johnson & Johnson scheduled to participate on Monday, January 12, 2026.
During the event, senior management from Johnson & Johnson will take part in a Fireside Chat at 11:15 a.m. Eastern Time, offering insights into the company’s strategic priorities, innovation pipeline, and outlook within the evolving healthcare landscape. A live audio webcast of the presentation will be accessible through the company’s Investor Relations website, with an archived replay available approximately 48 hours after the live session.
Key Highlights of Johnson & Johnson’s Participation
- Presentation at the 44th Annual J.P. Morgan Healthcare Conference, one of the most influential healthcare investor events globally.
- Fireside Chat with company leadership scheduled for January 12, 2026, at 11:15 a.m. ET.
- Live webcast and archived replay available via Johnson & Johnson’s Investor Relations portal.
- Opportunity for investors, analysts, and industry stakeholders to hear leadership perspectives on business strategy and future growth initiatives.
Industry observers view the J.P. Morgan Healthcare Conference as a key annual forum where major healthcare companies outline strategic priorities, share progress on therapeutic innovation, and engage with investors on long‑term growth opportunities. Johnson & Johnson’s participation underscores its continued engagement with the broader investment community while highlighting its evolving role across pharmaceuticals, medical technology, and consumer health sectors.
For investors and interested participants, the webcast provides a real‑time window into company leadership’s vision and offers valuable context on how Johnson & Johnson is positioning itself amid ongoing developments in global healthcare innovation.
